YOUR BUSINESS AUTHORITY
Springfield, MO
A weight-loss treatment from Eli Lilly has been given regulatory approval by the United States and United Kingdom.
Zepbound is expected to hit store shelves in the United States later this month.
Zepbound reportedly will be a rival to Novo Nordisk's Wegovy treatment.
Read more from Reuters.
Property enhancements include additional parking and luxury suites tower.